FREMONT, Calif., April 30, 2024 (GLOBE NEWSWIRE) Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, continues its commitment to advancing the cell analysis market by actively
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ A clinical study to explore the influence of BR1 on rheumatoid arthritis conducted by Professor Gregory J. Tsai from China Medical University.
In a study that will be published in Nature Communications on May 28, 2021, a research team led by Dr. Yuan Liu from Georgia State University reports that intratumoral SIRPalpha-deficient macrophages activate tumor antigen-specific cytotoxic T cells to eliminate various syngeneic cancers under radiotherapy. Their study identifies SIRPalpha as a master regulator controling macrophage immune responses and has demonstrated that intratumoral injection of SIRPalpha-depleted macrophages combined with local radiation is an effective strategy to treat different tumors